Mitsuko Nakajima

Mitsuko Nakajima

Auto-generated profile, based on publicly available information

Mitsuko Nakajima

UCL Huntington’s Disease Centre, UCL Queen Square Institute of Neurology

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 December 2023 in medRxiv
Verified
Preprint
Open access
PDF file
ACAnnabelle Coleman
Annabelle Coleman
ATAlexiane Touzé
Alexiane Touzé
MFMena Farag
Mena Farag
MPMarta Pengo
Marta Pengo
MMMichael J Murphy
Michael J Murphy
LBLauren M Byrne
Lauren M Byrne
Promising blood-based biomarkers of neuropathology have emerged with potential for therapeutic development and disease monitoring. However, these tools will require specialist tertiary services for integration into clinical management. Remote sampling for biomarker assessment could ease the burden of in-person clinical visits for such tests and allow for frequent sampling. Here we evaluated a capillary finger-prick collection for remote quantification of blood neurofilament light (NfL), a common blood-based biomarker evident in various neurological disorders, and other exploratory markers of neuronal injury and neuroinflammation (GFAP, tau). Matched samples from venepuncture and finger-prick were collected and processed into plasma and/or serum to directly compare NfL levels across four different neurological conditions (HD, MS, ALS, PD). Two delayed processing conditions were compared, three- and seven-day delay, simulating ambient shipment. Capillary NfL and GFAP concentrations were equivalent to those in venous blood serum and plasma. Only NfL remained stable after seven-day processing delay. Capillary NfL replicated disease group differences displayed in venous blood. This data supports our finger-prick method for remote collection and quantification of NfL. With the widespread applications for NfL across the spectrum of neurological disorders, this has the potential to transform disease monitoring, prognosis, and therapeutic development within clinical practice and research. Graphical Figure 1

1 January 2022 in Journal of Clinical Neurology
Verified
Journal Article
Open access
PDF file
MNMitsuko Nakajima
Mitsuko Nakajima
MPMathilde Pauls
Mathilde Pauls
SRSanjeev Rajakulendran
Sanjeev Rajakulendran
Nakajima M, et al. J Clin Neurol. 2022 Jan;18(1):105-107. https://doi.org/10.3988/jcn.2022.18.1.105